Advanced search
Publication Cover
Seminars in Ophthalmology Volume 34, 2019 - Issue 6
Submit an article Journal homepage
566
Views
11
CrossRef citations to date
0
Altmetric
Reviews

Intravitreal Ziv-Aflibercept: A Comprehensive Review

Daniel Barmas-AlamdariDepartment of Ophthalmology, Eastern Virginia Medical School, Norfolk, Virginia, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-0556-2438
ORCID Icon,
Haley S. D’SouzaDepartment of Ophthalmology, Eastern Virginia Medical School, Norfolk, Virginia, USA;Ophthalmology Research, Wagner Macula and Retina Center, Virginia Beach, Virginia, USAORCID Iconhttps://orcid.org/0000-0002-0938-1650
ORCID Icon,
Kapil G. KapoorDepartment of Ophthalmology, Eastern Virginia Medical School, Norfolk, Virginia, USA;Ophthalmology Research, Wagner Macula and Retina Center, Virginia Beach, Virginia, USA
&
Alan L. WagnerDepartment of Ophthalmology, Eastern Virginia Medical School, Norfolk, Virginia, USA;Ophthalmology Research, Wagner Macula and Retina Center, Virginia Beach, Virginia, USA
Pages 420-435 | Received 30 Dec 2018, Accepted 04 Jul 2019, Published online: 17 Jul 2019

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Fernando Munayco-Guillén, Miguel Angel Vazquez-Membrillo, Marlon Rafael Garcia-Roa, Jhony Alberto De La Cruz-Vargas, Herney Andrés García-Perdomo & Rafael Pichardo-Rodriguez. (2023) Effectiveness of the Use of Three-Dose Intravitreal Ziv-Aflibercept in the Management of Diabetic Macular Edema in a Real-Life Setting. Clinical Ophthalmology 17, pages 1129-1135.
Read now
Lorenzo Ferro Desideri, Carlo Enrico Traverso & Massimo Nicolò. (2021) Brolucizumab: a novel anti-VEGF humanized single-chain antibody fragment for treating w-AMD. Expert Opinion on Biological Therapy 21:5, pages 553-561.
Read now
Haley S. D’Souza, Kapil G. Kapoor & Alan L. Wagner. (2021) Ziv-aflibercept for Better Regulating Neovascular Age-Related Macular Degeneration (ZEBRA): A Prospective, Randomized Trial. Seminars in Ophthalmology 36:1-2, pages 28-34.
Read now
Elio Striglia, Andrea Caccioppo, Niccolò Castellino, Michele Reibaldi & Massimo Porta. (2020) Emerging drugs for the treatment of diabetic retinopathy. Expert Opinion on Emerging Drugs 25:3, pages 261-271.
Read now

Articles from other publishers (7)

Ajmal Ahmad & Mohd Imtiaz Nawaz. (2022) Molecular mechanism of VEGF and its role in pathological angiogenesis. Journal of Cellular Biochemistry 123:12, pages 1938-1965.
Crossref
Rahela Zaman, Rowshan Ara Islam & Ezharul Hoque Chowdhury. (2022) Evolving therapeutic proteins to precisely kill cancer cells. Journal of Controlled Release 351, pages 779-804.
Crossref
Faruque Ghanchi, Rupert Bourne, Susan M. Downes, Richard Gale, Christina Rennie, Ian Tapply & Sobha Sivaprasad. (2022) An update on long-acting therapies in chronic sight-threatening eye diseases of the posterior segment: AMD, DMO, RVO, uveitis and glaucoma. Eye 36:6, pages 1154-1167.
Crossref
Mozhdeh ZAMANI, Behnam KADKHODAEI, Navid NEZAFAT & Seyed V. HOSSEINI. (2022) In-silico selection of the signal peptides for high-level secretory expression of aflibercept in CHO cells. Minerva Biotechnology and Biomolecular Research 34:1.
Crossref
Heather G Mack, Mark Hassall, Anthony J H Hall, Matthew P Simunovic, Samantha Fraser-Bell & Lauren N Ayton. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology 693 731 .
Ahmad M. Mansour, Michael W. Stewart, Michel E. Farah, Hana A. Mansour & Jay Chhablani. (2019) Ziv‐aflibercept: A cost‐effective, off‐label, highly potent antagonist of vascular endothelial growth factor. Acta Ophthalmologica 98:5.
Crossref
Eduardo Tomazoni & Eduardo Buchelle Rodrigues. 2020. Choroidal Neovascularization. Choroidal Neovascularization 331 341 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.